Vinyl amide copolymer and method for producing same, vinyl amide copolymer composition, coating agent for medical use, coating material for medical use, and medical device
The vinylamide copolymer composition addresses the balance between adhesion and elution resistance in medical coating agents by using a high vinylamide monomer content with hydrophilic and hydrophobic units, improving both adhesion and elution resistance for medical devices.
Patent Information
- Application Number
- PCT/JP2024/024015
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-07-11
- Filing Date
- 2024-07-03
- Publication Date
- 2025-01-16
AI Technical Summary
Current medical coating agents for medical devices struggle to achieve a balance between high adhesion resistance and elution resistance, with existing copolymers often exhibiting high elution resistance at the expense of adhesion resistance, making them unsuitable for medical applications.
A vinylamide copolymer composition is developed, comprising a polymer block with 50 mol% or more vinylamide monomer units, combined with hydrophilic and hydrophobic monomer units, to create a coating that imparts both high adhesion resistance and elution resistance, suitable for medical devices.
The vinylamide copolymer composition effectively enhances the adhesion resistance and elution resistance of medical devices, preventing blood clot formation and extending the lifespan of the coating, making it suitable for medical applications.
Smart Images

Figure JPOXMLDOC01-APPB-T000001
Abstract
Description
Vinylamide copolymer and method for producing the same, vinylamide copolymer composition, medical coating agent, medical covering material, and medical device
[0001] The present invention relates to a vinylamide copolymer and a method for producing the same, a vinylamide copolymer composition containing the vinylamide copolymer, a medical coating agent containing the vinylamide copolymer, a medical covering material which is a coating film of the medical coating agent, and a medical device having the medical covering material.
[0002] Recently, there are a wide variety of medical devices that come into contact with living bodies, including heart-lung machines, dialysis machines, artificial blood vessels, stents, contact lenses, and catheters. The surfaces of these medical devices are required to have properties that inhibit the adhesion of macromolecules such as proteins, thereby suppressing the occurrence of thrombi caused by the adhesion, and ultimately preventing vascular occlusion due to thrombi and tissue necrosis due to ischemia. Therefore, medical coating agents that can impart resistance to the adhesion of macromolecules to the surfaces of medical devices (hereinafter, "resistance to the adhesion of macromolecules" will also be simply referred to as "adhesion resistance") have attracted attention.
[0003] Medical coating agents are required to not only have adhesion resistance to the polymer, but also resistance to elution in order to prevent the polymer from leaking into the body and to extend the life of the coating formed by the medical coating agent. The adhesion resistance of the polymer is primarily achieved by covering the surface of the medical device with water molecules, making it difficult for the polymer to bind to the surface, so medical coating agents are required to be hydrophilic. On the other hand, the elution resistance is a property based on the hydrophobic interaction between the surface of the medical device and the medical coating agent, so medical coating agents are required to be hydrophobic. Therefore, it is desirable for medical coating agents to have both high adhesion resistance and high elution resistance, i.e., to possess both hydrophilic and hydrophobic properties.
[0004] The main component of medical coating agents is generally a copolymer made from various monomers, such as hydrophilic and hydrophobic monomers. One copolymer that exhibits high adhesion resistance is a vinylamide copolymer containing vinylamide monomer units formed by the polymerization of vinylamide monomers. Patent Document 1 discloses a copolymer containing a polymer block formed by polymerizing a vinyl lactam monomer, a type of vinylamide monomer, and a hydrophobic monomer in any order, and a polymer block formed by polymerizing a hydrophobic monomer. It is also described that the copolymer can be used in hair products and cosmetic products.
[0005] Japanese Patent Application Laid-Open No. 2005-089754
[0006] However, the copolymer disclosed in Patent Document 1 has a high proportion of hydrophobic monomer units and a low proportion of hydrophilic monomer units, and therefore, although high resistance to elution can be expected, high resistance to adhesion cannot be expected, which poses a problem that application to medical coating agents is difficult.
[0007] The present invention has been made in view of the above-mentioned circumstances, and aims to provide a vinylamide-based copolymer that can impart high adhesion resistance to the surface of a medical device and has excellent resistance to elution, a method for producing the same, a vinylamide-based copolymer composition containing the vinylamide-based copolymer, a medical coating agent containing the vinylamide-based copolymer, a medical covering material that is a coating film of the medical coating agent, and a medical device having the medical covering material.
[0008] The present inventors have conducted extensive research into the above-mentioned problems and have found that the following invention can solve the above-mentioned problems, thereby completing the present invention. The present invention relates to the following [1] to
[16] . [1] A vinylamide copolymer comprising at least one polymer block (A) containing 50 mol% or more vinylamide-based monomer units and at least one polymer block (B) containing hydrophilic monomer units and hydrophobic monomer units. [2] The vinylamide copolymer according to [1] above, wherein the vinylamide-based monomer constituting the vinylamide-based monomer units comprises at least one selected from the group consisting of vinylacetamide, vinylpyrrolidone, vinylcaprolactam, vinylmethylacetamide, vinylformamide, vinylcarbazole, vinylimidazole, vinylphthalimide, vinylnaphthalimide, and vinylindole. [3] The vinylamide copolymer according to [1] or [2] above, wherein the hydrophilic monomer constituting the hydrophilic monomer units comprises at least one selected from the group consisting of vinylacetamide, vinylpyrrolidone, and vinylcaprolactam. [4] The vinylamide copolymer according to any one of [1] to [3] above, wherein the hydrophobic monomer constituting the hydrophobic monomer unit comprises at least one selected from the group consisting of acrylate monomers, acrylamide monomers, and styrene monomers. [5] The vinylamide copolymer according to any one of [1] to [4] above, wherein the content of the hydrophobic monomer constituting the hydrophobic monomer unit is 2 to 60 mol % based on 100 mol % of all monomers constituting the vinylamide copolymer. [6] The vinylamide copolymer according to any one of [1] to [5] above, wherein the ratio MA / MB of the molar amount MA of the polymer block (A) to the molar amount MB of the polymer block (B) is 5 / 95 to 95 / 5. [7] The vinylamide copolymer according to any one of [1] to [6] above, wherein the content of the hydrophilic monomer constituting the hydrophilic monomer unit is 30 to 97 mol % based on 100 mol % of all monomers constituting the polymer block (B). [8] The vinylamide copolymer according to any one of the above [1] to [7], wherein the molar amount M of the vinylamide copolymer is 300 to 5,000.[9] The vinylamide copolymer according to any one of [1] to [8] above, wherein the content of the vinylamide monomer constituting the vinylamide monomer units is 96 mol % or more, based on 100 mol % of all monomers constituting the polymer block (A).
[10] A method for producing a vinylamide copolymer, comprising at least one step each of: step (A) polymerizing a vinylamide monomer to produce a polymer block (A) containing vinylamide monomer units; and step (B) polymerizing a hydrophilic monomer and a hydrophobic monomer to produce a polymer block (B) containing hydrophilic monomer units and hydrophobic monomer units.
[11] A method for producing the vinylamide copolymer according to
[10] above, wherein the polymerization is carried out in the presence of a polymerization inhibitor in at least one step selected from the group consisting of step (A) and step (B).
[12] A vinylamide copolymer composition comprising the vinylamide copolymer according to any one of [1] to [9] above, and one or more ingredients selected from the group consisting of cinnamic acids, organic cobalt complexes, and thiocarbonyl compounds.
[13] A medical coating agent comprising the vinylamide copolymer described in any one of [1] to [9] above.
[14] A medical coating agent comprising the vinylamide copolymer composition described in
[12] above.
[15] A medical dressing material which is a coating film of the medical coating agent described in
[13] or
[14] above.
[16] A medical device comprising the medical dressing material described in
[15] above.
[0009] According to the present invention, it is possible to provide a vinylamide-based copolymer that can impart high adhesion resistance to the surface of a medical device and has excellent resistance to elution, a method for producing the same, a vinylamide-based copolymer composition containing the vinylamide-based copolymer, a medical coating agent containing the vinylamide-based copolymer, a medical covering material that is a coating film of the medical coating agent, and a medical device having the medical covering material.
[0010] An embodiment of the present invention will be described in detail below, but the present invention is not limited to the following embodiment. In the numerical ranges described in this specification, the upper or lower limit of the numerical range may be replaced with the values shown in the examples. In addition, the lower and upper limits of a numerical range can be arbitrarily combined with the lower and upper limits of other numerical ranges, respectively. Furthermore, when the exemplified and preferred aspects are a collection of options, any number of options can be extracted from the collection, and the extracted options can be arbitrarily combined with aspects described elsewhere. Aspects obtained by arbitrarily combining the items described in this specification are also included in the present invention.
[0011] The term "monomer unit" used herein refers to a "monomer" that has been incorporated into a polymer through a polymerization reaction and has undergone a structural change as a result. For example, a vinylamide-based monomer unit refers to a vinylamide-based monomer that has been incorporated into a polymer or copolymer through a polymerization reaction and has undergone a structural change. In this specification, "solid content" refers to components excluding the solvent. In this specification, "room temperature" refers to the ambient temperature without temperature control such as heating or cooling, and is generally around 25°C, but is not limited to the above range as this may vary depending on the weather and season.
[0012] The "hydrophilic monomer" described in this specification has a solubility parameter (SP value) of 10.7 (cal / cm 3 ) 1/2 The term "hydrophobic monomer" refers to a monomer having a solubility parameter (SP value) of 10.7 (cal / cm 3 ) 1/2 It means the following monomers: In the present invention, the solubility parameter defined by the Fedors method can be calculated by the method described in Polym. Eng. Sci. 14(2)152, (1974).
[0013] The term "(meth)" used in compounds, materials, monomers, etc. in this specification means that the structure of the compound, material, monomer, etc. includes those that have a structure represented by "meth" and those that do not have a structure represented by "meth." For example, "methyl (meth)acrylate" means that two types of acrylates, methyl methacrylate and methyl acrylate, are included.
[0014] As used herein, the term "molar weight MA" refers to a value determined by dividing the number average molecular weight Mn(A) of polymer block (A) by the sum of the molecular weights of the various monomer units constituting polymer block (A). As used herein, the term "molar weight MB" refers to a value determined by dividing the number average molecular weight Mn(B) of polymer block (B) by the sum of the molecular weights of the various monomer units constituting polymer block (B). As used herein, the term "molar weight M" refers to a value expressed as the sum of the molar weight MA of polymer block (A) and the molar weight MB of polymer block (B). As used herein, the term "number average molecular weight Mn (including number average molecular weight Mn(A), number average molecular weight Mn(B), etc.)" refers to a value measured using a gel permeation chromatography (GPC) apparatus.
[0015] The vinylamide copolymer according to this embodiment is a vinylamide copolymer containing at least one polymer block (A) containing 50 mol % or more of vinylamide monomer units and at least one polymer block (B) containing hydrophilic monomer units and hydrophobic monomer units.
[0016] [Polymer Block (A)] The polymer block (A) is not particularly limited as long as it contains 50 mol% or more vinylamide-based monomer units, and may contain other monomer units besides the vinylamide-based monomer units. The other monomer units are not particularly limited, and examples thereof include hydrophilic monomer units and hydrophobic monomer units described below. The polymer block (A) may contain one or more blocks in the vinylamide-based copolymer, or may contain two or more blocks. The polymer block (A) may contain one or more types of vinylamide-based monomer units, or may contain two or more types of vinylamide-based monomer units. The arrangement of the vinylamide-based monomer units (including multiple types of vinylamide-based monomer units) and other monomer units in the polymer block (A) is not particularly limited.
[0017] The number-average molecular weight Mn(A) of the polymer block (A) is preferably 10,000 to 100,000. When it is 10,000 or more, the ability of the polymer block (A) to form phase-separated domains is sufficiently ensured, and the adhesion resistance of the polymer is easily improved. When it is 100,000 or less, an increase in the viscosity of the vinylamide copolymer due to an increase in the molecular weight of the vinylamide copolymer is unlikely to occur, resulting in excellent handleability. From this viewpoint, the total content is more preferably 20,000 to 90,000, and even more preferably 28,000 to 80,000. The "number-average molecular weight Mn(A)" here is measured using the same method as in the examples.
[0018] When two or more polymer blocks (A) are present in the vinylamide copolymer, the number average molecular weight Mn(A) refers to the sum of the number average molecular weights of all polymer blocks (A). In this specification, the polymer blocks (A) present in the vinylamide copolymer in order from the end are referred to as polymer block (A1), polymer block (A2), polymer block (A3), ..., polymer block (An), and their number average molecular weights Mn(A) are referred to as number average molecular weight Mn(A1), number average molecular weight Mn(A2), number average molecular weight Mn(A3), ..., number average molecular weight Mn(An). The ends of the vinylamide copolymer may be polymerization initiation ends or polymerization termination ends.
[0019] The molar mass MA of the polymer block (A) is preferably 50 to 1,000. When it is 50 or more, the ability of the polymer block (A) to form phase-separated domains is sufficiently ensured, and the adhesion resistance of the polymer is easily improved. When it is 1,000 or less, an increase in the viscosity of the vinylamide copolymer due to an increase in the molecular weight of the vinylamide copolymer is unlikely to occur, resulting in excellent handleability. From this viewpoint, the total content is more preferably 150 to 850, and even more preferably 250 to 700. The "molar mass MA" here is measured by the same method as in the examples.
[0020] [[Vinylamide Monomer]] The vinylamide monomer is not particularly limited, and examples thereof include vinylacetamide, vinylpyrrolidone, vinylcaprolactam, vinylmethylacetamide, vinylformamide, vinylcarbazole, vinylimidazole, vinylphthalimide, vinylnaphthalimide, and vinylindole. These may be used alone or in combination of two or more. Among these, from the viewpoint of adhesion resistance of the polymer, vinylacetamide, vinylpyrrolidone, and vinylcaprolactam are preferred, and vinylpyrrolidone and vinylcaprolactam are more preferred.
[0021] The total content of vinylamide monomer units in the polymer block (A) is preferably 50 mol % or more, more preferably 96 mol % or more, and even more preferably 100 mol % from the viewpoint of adhesion resistance of the polymer.
[0022] [Polymer Block (B)] The polymer block (B) is not particularly limited as long as it contains a hydrophilic monomer unit and a hydrophobic monomer unit, and may contain a monomer unit other than the hydrophilic monomer unit and the hydrophobic monomer unit to the extent that the effects of the present invention are not impaired. Furthermore, the polymer block (B) may be contained in one or more blocks in the vinylamide copolymer, or may be contained in two or more blocks. The arrangement of the hydrophilic monomer unit, the hydrophobic monomer unit, and the other monomer units in the polymer block (B) is not particularly limited.
[0023] The number-average molecular weight Mn(B) of the polymer block (B) is preferably 10,000 to 400,000. When it is 10,000 or more, the ability of the polymer block (B) to form phase-separated domains is sufficiently ensured, and elution resistance is easily improved. When it is 400,000 or less, an increase in the viscosity of the vinylamide copolymer due to an increase in the molecular weight of the vinylamide copolymer is unlikely to occur, resulting in excellent handleability. From this perspective, the total content is more preferably 35,000 to 350,000, and even more preferably 50,000 to 300,000. The "number-average molecular weight Mn(B)" here is measured using the same method as in the examples.
[0024] In the present embodiment, when two or more polymer blocks (B) are present in the vinylamide copolymer, the number average molecular weight Mn(B) refers to the sum of the number average molecular weights of all polymer blocks (B). In this specification, the polymer blocks (B) present in the vinylamide copolymer in order from the end are referred to as polymer block (B1), polymer block (B2), polymer block (B3), ..., polymer block (Bn), and their number average molecular weights Mn(B) are referred to as number average molecular weight Mn(B1), number average molecular weight Mn(B2), number average molecular weight Mn(B3), ..., number average molecular weight Mn(Bn). The end of the vinylamide copolymer is not particularly limited and may be a polymerization initiation end or a polymerization termination end.
[0025] The molar mass MB of the polymer block (B) is preferably 200 to 3,000. When it is 200 or more, the ability of the polymer block (B) to form a phase-separated domain is sufficiently ensured, and elution resistance is easily improved. When it is 3,000 or less, an increase in the viscosity of the vinylamide copolymer due to an increase in the molecular weight of the vinylamide copolymer is unlikely to occur, resulting in excellent handleability. From this viewpoint, the total content is more preferably 300 to 2,500, and even more preferably 400 to 2,000. The "molar mass MB" here is measured by the same method as in the examples.
[0026] [Hydrophilic Monomer] The hydrophilic monomer is not particularly limited as long as it is a monomer that exhibits hydrophilicity upon polymerization, and examples thereof include (meth)acrylic acid; (meth)acrylate-based monomers such as 2-hydroxymethyl(meth)acrylate, hydroxyethyl(meth)acrylate, hydroxypropyl(meth)acrylate, hydroxybutyl(meth)acrylate, (meth)acryloyloxyethylphosphorylcholine, carboxybetaine(meth)acrylate, phosphobetaine(meth)acrylate, and sulfobetaine(meth)acrylate; (meth)acrylamide, N-hydroxymethyl(meth)acrylamide, N-hydroxyethyl(meth)acrylamide, acryloylmorpholine, acrylamido-2-methylpropanesulfonic acid and its sodium salt and potassium salt, trime Examples of such monomers include (meth)acrylamide-based monomers such as methyl[3-(methacryloylamino)propyl]ammonium chloride; allyl-based monomers such as 2-methylene-1,3-propanediol, (meth)allyl alcohol, and dimethylallyl alcohol; vinyl alcohol; (meth)acrylonitrile; styrene-based monomers such as p-styrenesulfonic acid and its sodium salt and potassium salt; vinyl ether-based monomers such as hydroxymethyl vinyl ether, hydroxyethyl vinyl ether, hydroxypropyl vinyl ether, and hydroxybutyl vinyl ether; and dicarboxylic acid-based monomers such as maleic acid, monomethyl maleate, itaconic acid, monomethyl itaconate, fumaric acid, monomethyl fumarate, crotonic acid, methylenemalonic acid, and monomethyl methylenemalonate. These monomers may be used alone or in combination of two or more. Among these, from the viewpoint of the balance between hydrophilicity and hydrophobicity, 2-hydroxyethyl methacrylate, methacryloyloxyethyl phosphorylcholine, carboxybetaine methacrylate, phosphobetaine methacrylate, and sulfobetaine methacrylate are preferred, and 2-hydroxyethyl methacrylate is more preferred.
[0027] The hydrophilic monomer is not particularly limited, and a vinylamide-based monomer may be used, such as vinylacetamide, vinylpyrrolidone, vinylcaprolactam, vinylmethylacetamide, vinylformamide, etc. These may be used alone or in combination of two or more. Among these, from the viewpoint of the balance between hydrophilicity and hydrophobicity, vinylacetamide, vinylpyrrolidone, and vinylcaprolactam are preferred, and vinylpyrrolidone and vinylcaprolactam are more preferred. The hydrophilic monomer may be the same vinylamide-based monomer as that used in the polymer block (A).
[0028] The content (W) of hydrophilic monomer units in polymer block (B) is preferably 30 to 97 mol%. When it is 30 mol% or more, hydrophilicity is imparted to the vinylamide copolymer, which makes it easier to improve adhesion resistance. When it is 97 mol% or less, hydrophobicity is imparted to the vinylamide copolymer, which makes it excellent in elution resistance. From this viewpoint, the total content is more preferably 35 to 95 mol%, and even more preferably 50 to 90 mol%. Here, "the content (W) of hydrophilic monomer units in polymer block (B)" is measured by the same method as in the examples.
[0029] [Hydrophobic Monomer] The hydrophobic monomer is not particularly limited as long as it is a monomer that exhibits hydrophobicity upon polymerization, and examples thereof include acrylate-based monomers, acrylamide-based monomers, styrene-based monomers, olefin-based monomers, and vinylamide-based monomers. These may be used alone or in combination of two or more. Among these, acrylate-based monomers and acrylamide-based monomers are preferred from the viewpoints of polymerizability and hydrophobicity.
[0030] The acrylate monomer is not particularly limited, and examples thereof include methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, butyl (meth)acrylate, pentyl (meth)acrylate, hexyl (meth)acrylate, heptyl (meth)acrylate, octyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, dodecyl (meth)acrylate, lauryl acrylate, cyclohexyl (meth)acrylate, methylcyclopentyl (meth)acrylate, norbornyl (meth)acrylate, and isobornyl (meth)acrylate. acrylate, adamantyl (meth)acrylate, 2-methoxyethyl (meth)acrylate, methoxybutyl (meth)acrylate, polyethylene glycol (meth)acrylate, polypropylene glycol (meth)acrylate, tetrahydrofurfuryl (meth)acrylate, phenyl (meth)acrylate, benzyl (meth)acrylate, glycidyl (meth)acrylate, phenoxyethyl (meth)acrylate, dimethyl maleate, maleic anhydride, dimethyl itaconate, itaconic anhydride, dimethyl fumarate, dimethyl methylenemalonate, and the like. These may be used alone or in combination of two or more. Of these, butyl acrylate, 2-methoxyethyl acrylate, and 2-ethylhexyl acrylate are preferred from the viewpoint of the balance between polymerizability and hydrophobicity.
[0031] The acrylamide monomer is not particularly limited, and examples thereof include N-methylol(meth)acrylamide, N,N-dimethyl(meth)acrylamide, N,N-diethyl(meth)acrylamide, N-propyl(meth)acrylamide, N-isopropyl(meth)acrylamide, N-butyl(meth)acrylamide, N-pentyl(meth)acrylamide, N-hexyl(meth)acrylamide, N-heptyl(meth)acrylamide, N-octyl(meth)acrylamide, N-dodecyl(meth)acrylamide, N-cyclohexyl(meth)acrylamide, N-norbornyl(meth)acrylamide, and N-isobornyl Examples of such acrylamide include (meth)acrylamide, adamantyl (meth)acrylamide, methoxymethyl (meth)acrylamide, methoxyethyl (meth)acrylamide, methoxybutyl (meth)acrylamide, N-phenyl (meth)acrylamide, N-benzyl (meth)acrylamide, N-isobutoxymethyl (meth)acrylamide, diacetone (meth)acrylamide, N-dimethylaminoethyl (meth)acrylamide, N-diethylaminoethyl (meth)acrylamide, N-dimethylaminopropyl (meth)acrylamide, methylene bis(meth)acrylamide, and ethylene bis(meth)acrylamide. These may be used alone or in combination of two or more. Among these, N,N-dimethylacrylamide, N,N-diethylacrylamide, and N-octylacrylamide are preferred from the viewpoints of polymerizability and hydrophobicity.
[0032] The styrene-based monomer is not particularly limited, and examples thereof include styrene, α-methylstyrene, vinylpyridine, vinylnaphthalene, vinylanthracene, divinylbenzene, etc. These may be used alone or in combination of two or more. Among these, styrene is preferred from the viewpoint of polymerizability.
[0033] The olefin-based monomer is not particularly limited, and examples thereof include ethylene, propylene, isobutylene, 1-butene, 1-pentene, 1-hexene, 1-pentene, 1-octene, vinyl chloride, vinyl fluoride, vinylidene chloride, vinylidene fluoride, and vinylidene cyanide. These may be used alone or in combination of two or more. Among these, ethylene, propylene, and isobutylene are preferred from the viewpoints of polymerizability and hydrophobicity.
[0034] The total content of hydrophobic monomer units in the polymer block (B) is preferably 3 to 70 mol%. When the content is 3 mol% or more, it is easy to improve the elution resistance. When the content is 70 mol% or less, the adhesion resistance of the polymer is excellent. From this viewpoint, the total content is more preferably 5 to 65 mol%, and even more preferably 10 to 50 mol%.
[0035] The hydrophobic monomer has a solubility parameter (SP value) of 10.7 (cal / cm 3 ) 1/2 The monomer is not particularly limited as long as it is one of the following, and may be a vinylamide monomer, such as vinyl carbazole, vinyl imidazole, vinyl phthalimide, vinyl naphthalimide, or vinyl indole. These may be used alone or in combination of two or more. Among these, vinyl carbazole is preferred from the viewpoint of hydrophobicity.
[0036] The content (Z) of hydrophobic monomer units in the vinylamide copolymer is preferably 2 to 60 mol%. When the content (Z) is 2 mol% or more, it is easy to improve the elution resistance. When the content (Z) is 60 mol% or less, the adhesion resistance of the polymer is excellent. From this viewpoint, the content (Z) is more preferably 4 to 50 mol%, and even more preferably 7 to 40 mol%. Here, "the content (Z) of hydrophobic monomer units in the vinylamide copolymer" is measured by the same method as in the examples.
[0037] [MA / MB] The ratio MA / MB of the molar amount MA of the polymer block (A) to the molar amount MB of the polymer block (B) in the vinylamide copolymer is preferably 5 / 95 to 95 / 5. When MA / MB is 5 / 95 or more, the adhesion resistance of the polymer is easily improved. When MA / MB is 95 / 5 or less, the elution resistance is excellent. From this viewpoint, the ratio MA / MB is more preferably 10 / 90 to 90 / 10, and even more preferably 15 / 85 to 85 / 15.
[0038] [Other Blocks] The vinylamide copolymer according to the present embodiment may or may not contain a polymer block (C) other than the polymer block (A) and the polymer block (B), as long as the effects of the present invention are not impaired. From the viewpoint of adhesion resistance and elution resistance of the polymer, the total content of the polymer block (A) and the polymer block (B) in the vinylamide copolymer according to the present embodiment is preferably 50 to 100 mol %, more preferably 80 to 100 mol %, and even more preferably 95 to 100 mol %.
[0039] [Number-Average Molecular Weight Mn of Vinylamide Copolymer] The number-average molecular weight Mn of the vinylamide copolymer is the sum of the number-average molecular weight Mn(A) of the polymer block (A) and the number-average molecular weight Mn(B) of the polymer block (B), and is preferably 50,000 to 450,000. When it is 50,000 or more, it is easy to improve the elution resistance, film-forming properties, and mechanical properties of the coating film. When it is 450,000 or less, it is excellent in moldability and handleability. From this viewpoint, the total content is more preferably 65,000 to 300,000, and even more preferably 80,000 to 200,000.
[0040] [Molar amount M of vinylamide copolymer] The molar amount M of the vinylamide copolymer is the total molar amount of all monomer units in the polymer block (A) and the polymer block (B), and is preferably 300 to 5,000. When it is 300 or more, it is easy to improve the elution resistance, film-forming properties, and mechanical properties of the coating film. When it is 5,000 or less, it is excellent in moldability and handleability. From this viewpoint, the total content is more preferably 400 to 3,500, and even more preferably 500 to 2,000.
[0041] [Method for Producing Vinylamide Copolymer] Hereinafter, the method for producing a vinylamide copolymer of the present invention will be described in detail with reference to specific embodiments, but the present invention is not limited to the following embodiments.
[0042] The method for producing a vinylamide copolymer according to this embodiment includes at least one step each of step (A) of polymerizing a vinylamide monomer to produce a polymer block (A) containing a vinylamide monomer unit, and step (B) of polymerizing a hydrophilic monomer and a hydrophobic monomer to produce a polymer block (B) containing a hydrophilic monomer unit and a hydrophobic monomer unit.
[0043] In the production method of the vinylamide copolymer according to the present embodiment, from the viewpoint of operational efficiency and production man-hours, it is preferable to continuously carry out one or more steps of the above step (A) and one or more steps of the above step (B). In addition to the above, the production method of the present embodiment may also include a production method in which step (A) and step (B) are carried out separately, and the polymer block (A) and polymer block (B) produced respectively are bonded via a radical reaction, a Huisgen cyclization reaction, a Diels-Alder reaction, an amide reaction, a thiol-ene reaction, a sulfur (IV)-fluorine exchange reaction, or the like to obtain a vinylamide copolymer. It should be noted that either step (A) or step (B) may be carried out first.
[0044] The steps (A) and (B) that may be included in the production method of this embodiment are preferably steps of polymerizing the monomers necessary for forming the polymer block (A) and the polymer block (B) by radical polymerization in the presence of the monomers and a radical polymerization initiator. In the step (A), a vinylamide-based monomer is polymerized, and in the step (B), a hydrophilic monomer and a hydrophobic monomer are polymerized. The polymer block (A) is produced by polymerizing the vinylamide-based monomer, and the polymer block (B) is produced by polymerizing the hydrophilic monomer and the hydrophobic monomer.
[0045] [Radical polymerization] The radical polymerization method is not particularly limited, and examples thereof include bulk polymerization, solution polymerization, suspension polymerization, emulsion polymerization, etc. One of these methods may be used alone, or two or more methods may be used in combination. Among these, the solution polymerization method is preferred from the viewpoint of heat removal and isolation of the vinylamide copolymer.
[0046] The reaction solvent used in the solution polymerization is not particularly limited, and examples thereof include methyl acetate, ethyl acetate, benzene, toluene, xylene, methanol, ethanol, n-propanol, isopropanol, butanol, acetone, dimethyl sulfoxide, dimethylformamide, tetrahydrofuran, 1,4-dioxane, methyl ethyl ketone, methyl isobutyl ketone, N-methyl-2-pyrrolidone, water, dimethyl carbonate, and diethyl carbonate. These solvents may be used alone or in combination of two or more. Among these, dimethyl carbonate, isopropanol, and methanol are preferred from the viewpoint of monomer solubility.
[0047] The amount of reaction solvent used is preferably 10 to 400 parts by mass per 100 parts by mass of the total of the monomers used in each step. When the amount used is 10 parts by mass or more, the polymerization rate is reduced, making it easier to suppress side reactions. On the other hand, when the amount used is 400 parts by mass or less, an improved yield of the target product can be expected. From this perspective, the amount is more preferably 30 to 300 parts by mass, and even more preferably 50 to 200 parts by mass.
[0048] [Radical Polymerization Initiator] The radical polymerization initiator is not particularly limited, and may be appropriately selected from known azo radical generators, peroxide radical generators, redox radical generators, etc. The azo radical generator is not particularly limited, and examples thereof include 2,2'-azobisisobutyronitrile, 2,2'-azobis(2,4-dimethylvaleronitrile), 2,2'-azobis(4-methoxy-2,4-dimethylvaleronitrile), etc. The peroxide radical generator is not particularly limited, and examples thereof include percarbonate compounds such as diisopropyl peroxydicarbonate, di-2-ethylhexyl peroxydicarbonate, and diethoxyethyl peroxydicarbonate; perester compounds such as t-butyl peroxyneodecanate, α-cumyl peroxyneodecanate, and t-butyl peroxyneodecanate; acetylcyclohexylsulfonyl peroxide, diisobutyryl peroxide; and 2,4,4-trimethylpentyl-2-peroxyphenoxyacetate. Furthermore, the radical generators described above can be combined with peroxides such as potassium persulfate, ammonium persulfate, and hydrogen peroxide to form radical generators. The redox radical generator is also not particularly limited, and examples thereof include combinations of the peroxides described above with reducing agents such as sodium hydrogen sulfite, sodium hydrogen carbonate, tartaric acid, L-ascorbic acid, and Rongalit. These compounds may be used alone or in combination of two or more. Among these, 2,2'-azobisisobutyronitrile, 2,2'-azobis(2,4-dimethylvaleronitrile), and 2,2'-azobis(4-methoxy-2,4-dimethylvaleronitrile) are preferred from the viewpoint of ease of handling.
[0049] The amount of radical polymerization initiator used is preferably 0.01 to 10.00 parts by mass per 100 parts by mass of the total of the monomers used in each step. When the amount used is 0.01 parts by mass or more, the polymerization time tends to be shortened favorably. On the other hand, when the amount used is 10.00 parts by mass or less, it is economical. From this viewpoint, the amount is more preferably 0.03 to 5.00 parts by mass, and even more preferably 0.1 to 1.00 parts by mass.
[0050] The additives used in step (A) and step (B) are not particularly limited as long as at least a monomer and a radical polymerization initiator are used, and may include a control agent and a modifying agent. From the viewpoint of molecular weight control, it is preferable to carry out polymerization in the presence of the control agent in at least one step selected from the group consisting of step (A) and step (B).
[0051] [Control agent] The control agent is not particularly limited, and examples thereof include organic cobalt complexes, organic iodine compounds, thiocarbonyl compounds, organic tellurium compounds, organic compounds having a redox center, organic compounds having a stable radical, mixtures of transition metal complexes such as copper or ruthenium with organic halides, cinnamic acids, etc. These may be used alone or in combination of two or more. Among these, from the viewpoint of production cost, organic cobalt complexes, organic compounds having a stable radical, thiocarbonyl compounds, and cinnamic acids are preferred, and from the viewpoint of low toxicity, cinnamic acids are more preferred.
[0052] The amount of the control agent used is preferably 0.01 to 5.00 parts by mass per 100 parts by mass of the total of the monomers used in each step, from the viewpoint of molecular weight control. If the amount used is 0.01 part by mass or more, a copolymer with the desired molecular weight is likely to be obtained. On the other hand, from the viewpoint of economy, the amount used is desirably 5.00 parts by mass or less. From this viewpoint, the amount is more preferably 0.03 to 3.00 parts by mass, and even more preferably 0.05 to 1.00 parts by mass.
[0053] [Organic Cobalt Complex] The organic cobalt complex is not particularly limited, and examples thereof include cobalt(II) porphyrin, cobalt(II) salen, and cobalt(II) acetylacetonate. These may be used alone or in combination of two or more. Among these, cobalt(II) acetylacetonate is preferred from the viewpoint of production cost.
[0054] [[Organic Compound Having a Stable Radical]] The organic compound having a stable radical is not particularly limited, and examples thereof include cinnamic alcohol, coumarin, β-ionone, 2,2,6,6-tetramethylpiperidine-1-oxyl, trans-benzalacetone, etc. These may be used alone or in combination of two or more. Of these, trans-benzalacetone is preferred from the viewpoint of production costs.
[0055] [[Thiocarbonyl Compound]] The thiocarbonyl compound is not particularly limited, and examples thereof include xanthates such as O-ethyl-S-(1-methoxycarbonylethyl)dithiocarbonate, O-ethyl-S-cyanomethylxanthate, O-ethyl-S-(1-isobutoxyethyl)xanthate, O-isopropyl-S-(1-isobutoxyethyl)xanthate, and O-ethyl-S-(1-acetoxy-3-cyanopropyl)xanthate; trithiocarbonates such as S-cyanomethyl-S-dodecyltrithiocarbonate, S-(2-cyanopropyl-2-yl)-S-dodecyltrithiocarbonate, and S-(1-isobutoxyethyl)-S-ethyltrithiocarbonate; cyanomethyl methyl(phenyl)carbamodithioate; and the like. These may be used alone or in combination of two or more. Among these, from the viewpoints of molecular weight controllability and economy, O-ethyl-S-(1-isobutoxyethyl)xanthate, S-(1-isobutoxyethyl)-S-ethyltrithiocarbonate, and cyanomethyl methyl(phenyl)carbamodithioate are preferred.
[0056] [Cinnamic Acids] The cinnamic acids are not particularly limited, and examples thereof include trans-cinnamic acid, methyl cinnamate, ethyl cinnamate, vinyl cinnamate, 2-hydroxycinnamic acid, 3-hydroxycinnamic acid, 4-hydroxycinnamic acid, 2-methoxycinnamic acid, 3-methoxycinnamic acid, 4-methoxycinnamic acid, 2-aminocinnamic acid, 3-aminocinnamic acid, 4-aminocinnamic acid, 2-phenylethyl cinnamate, caffeic acid, benzyl cinnamate, and isopropyl cinnamate. These may be used alone or in combination of two or more. Of these, trans-cinnamic acid and methyl cinnamate are preferred from the viewpoints of molecular weight control and economic efficiency.
[0057] [Modifying Agent] The modifying agent is not particularly limited, and examples thereof include thioacetic acid, thiopropionic acid, thiobutyric acid, thiophenol, methanethiol, ethanethiol, propanethiol, butanethiol, pentanethiol, decanethiol, dodecanethiol, hexadecanethiol, octadecanethiol, 2-ethylhexyl mercaptoacetate, ethyl mercaptoacetate, 2-mercaptoethanol, 3-mercapto-1,2-propanediol, mercaptoacetic acid, 3-mercaptopropionic acid, methyl mercaptoacetate, and mercaptosuccinic acid. These may be used alone or in combination of two or more. Of these, thioacetic acid is preferred from the viewpoint of being able to form chain transfer reaction sites at the polymer terminals.
[0058] The amount of the modifying agent used is preferably 0.001 to 5,000 parts by mass relative to 100 parts by mass of the total of the monomers used in each step. When the amount used is 0.001 part by mass or more, a good modification rate is easily achieved. On the other hand, when the amount used is 5,000 parts by mass or less, it is economical. From this viewpoint, the amount used is more preferably 0.005 to 3,000 parts by mass, and even more preferably 0.01 to 1,000 parts by mass.
[0059] [Reaction Temperature] The reaction temperature in step (A) and step (B) is not particularly limited, but from the viewpoint of molecular weight control, it is preferably 30 to 80°C, more preferably 35 to 70°C, and even more preferably 40 to 60°C.
[0060] [Polymerization Inhibitor] The production method of the present embodiment may include a method of terminating the polymerization reaction in step (A) and step (B) by adding a polymerization inhibitor when the molar amounts and number average molecular weights of the polymerized block (A) and polymerized block (B) reach the desired values. The polymerization inhibitor is not particularly limited, and examples thereof include 1,1-diphenylethylene, 4-methoxyphenol, hydroquinone, cresol, t-butylcatechol, p-nitrosophenol, benzoquinone, naphthoquinone, muconic acid, sorbic acid, phenothiazine, distearyl thiodipropionate, dilauryl thiodipropionate, p-phenylenediamine, N-nitrosodiphenylamine, 2,2,6,6-tetramethylpiperidine 1-oxyl, 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl, copper acetate, copper dithiocarbamate, and manganese acetate. These inhibitors may be used alone or in combination of two or more. Among these, 4-methoxyphenol and 1,1-diphenylethylene are preferred from the viewpoint of hue.
[0061] The amount of the polymerization inhibitor used is preferably 0.01 to 5.00 parts by mass per 100 parts by mass of the total of the monomers used in each step. When the amount used is 0.01 part by mass or more, the polymerization termination ability is easily improved. On the other hand, when the amount used is 5.00 parts by mass or less, it is economical. From this viewpoint, the amount used is more preferably 0.05 to 3.00 parts by mass, and even more preferably 0.10 to 2.00 parts by mass.
[0062] [Vinylamide copolymer composition] The vinylamide copolymer composition is not particularly limited as long as it contains at least a vinylamide copolymer, and may contain ingredients other than the vinylamide copolymer, such as cinnamic acids, organic cobalt complexes, thiocarbonyl compounds, etc., to the extent that the effects of the present invention are not impaired. These may be contained alone or in combination of two or more. The above-mentioned ingredients such as cinnamic acids, organic cobalt complexes, and thiocarbonyl compounds may be contained by any route without particular limitation, and may be derived from a polymerization inhibitor or from additives added after polymerization, such as a polymerization inhibitor, antioxidant, or deodorizer. Furthermore, the other ingredients are not particularly limited and may include, for example, solvents such as methyl acetate, ethyl acetate, benzene, toluene, xylene, methanol, ethanol, n-propanol, isopropanol, butanol, acetone, dimethyl sulfoxide, dimethylformamide, tetrahydrofuran, 1,4-dioxane, methyl ethyl ketone, methyl isobutyl ketone, N-methyl-2-pyrrolidone, water, dimethyl carbonate, diethyl carbonate, etc. These may be contained alone or in combination of two or more.
[0063] When the vinylamide copolymer composition contains the above-mentioned ingredients, the content of the ingredients in 100% by mass of the vinylamide copolymer composition is preferably 0.01 to 1.00% by mass. When the content is 0.01% by mass or more, oxidative deterioration during storage can be suppressed. When the content is 1.00% by mass or less, elution resistance is easily improved. From this viewpoint, the total content is more preferably 0.02 to 0.90% by mass, and even more preferably 0.03 to 0.80% by mass.
[0064] The content of the vinylamide copolymer in the total solid content (100% by mass) of the vinylamide copolymer composition according to the present embodiment is preferably 90 to 100% by mass, more preferably 95 to 100% by mass, and even more preferably 99 to 100% by mass, from the viewpoint of adhesion resistance and elution resistance of the polymer.
[0065] From the viewpoint of storage stability, the content of the solvent in 100% by mass of the vinylamide copolymer composition according to the present embodiment is preferably 0 to 50% by mass, more preferably 0 to 30% by mass, and even more preferably 0 to 10% by mass.
[0066] [Medical Coating Agent] The vinylamide copolymer and vinylamide copolymer composition according to the embodiment of the present invention have a good balance of hydrophilicity and hydrophobicity, and are therefore suitable for medical coating agents that can impart high adhesion resistance to medical devices and require excellent elution resistance. The content of the vinylamide copolymer or the vinylamide copolymer composition in the medical coating agent is not particularly limited, but is preferably 0.001 to 70.000% by mass. When the amount used is 0.001% or more, a coating layer with sufficient mechanical strength is easily formed. On the other hand, when the amount used is 70.000% by mass or less, good film-forming properties are achieved. From this viewpoint, the amount used is more preferably 0.005 to 50.000% by mass, and even more preferably 0.01 to 30.000% by mass.
[0067] The components in the medical coating agent other than the vinylamide copolymer and the vinylamide copolymer composition are not particularly limited as long as they do not impair the adhesion resistance and elution resistance of the polymers of the vinylamide copolymer and the vinylamide copolymer composition, and examples thereof include emulsifiers, viscosity modifiers, antioxidants, crosslinking agents, surfactants, pH adjusters, ultraviolet absorbers, wettability improvers, antifoaming agents, etc. These may be used alone or in combination of two or more.
[0068] [Medical Dressing and Medical Device] An embodiment of the present invention includes a medical dressing that is a coating film of the medical coating agent. Because the medical dressing has high adhesion resistance and excellent elution resistance derived from the medical coating, it is suitable for use in medical devices. Applications for the medical devices are not particularly limited, and examples include components for artificial biological tissues such as artificial blood vessels and artificial organs; components for devices that come into contact with biological tissues, such as blood filters, various catheters, various stents, various implants, and various guide wires; cell culture substrates; components for hemodialysis devices; components for blood or tissue testing instruments; components for devices that come into contact with biological components, including cells, blood, etc.
[0069] The present invention will be described in detail below with reference to examples. The following examples are provided to facilitate understanding of the present invention and are not intended to limit the present invention, and various modifications and improvements are possible within the scope of the present invention.
[0070] The various materials used in this example are listed below. The letters in parentheses after each material indicate the abbreviation or trade name of the material. [Controller] trans-cinnamic acid (CA) methyl cinnamate (MC) trans-benzalacetone (BZA) cobalt(II) acetylacetonate (Co(acac)2) methyl(phenyl)carbamodithioate cyanomethyl (BM1434) [Radical polymerization initiator] [2,2'-azobis(4-methoxy-2,4-dimethylvaleronitrile)] (V-70) azobisisobutyronitrile (AIBN) [Vinylamide monomer] N-vinyl-2-pyrrolidone (VP): SP value 11.4 (cal / cm 3 ) 1/2 N-vinyl-ε-caprolactam (CL): SP value 10.8 (cal / cm 3 ) 1/2 [Hydrophobic Monomer] 2-Ethylhexyl acrylate (EHA): SP value 8.62 (cal / cm 3 ) 1/2 Butyl acrylate (BA): SP value 8.82 (cal / cm 3 ) 1/22-Methoxyethyl acrylate (MEA): SP value 9.07 (cal / cm 3 ) 1/2 N-octylacrylamide (OAAm): SP value 10.6 (cal / cm 3 ) 1/2 Styrene (St): SP value 8.93 (cal / cm 3 ) 1/2 [Hydrophilic Monomer] 2-hydroxyethyl methacrylate (HEMA): SP value 12.06 (cal / cm 3 ) 1/2 [Polymerization inhibitor] 4-methoxyphenol (MEHQ) 1,1-diphenylethylene (DPEt) [Reaction solvent] Dimethyl carbonate (DMC) Isopropanol (IPA) Methanol (MeOH) [Modifier] Thioacetic acid (AcSH)
[0071] [Number Average Molecular Weight Mn] The number average molecular weight Mn of the polymer (including number average molecular weight Mn(A), number average molecular weight Mn(B), etc.) was measured using a gel permeation chromatography (GPC) device manufactured by Tosoh Corporation. The measurement conditions were as follows. <Conditions> Column: Organic solvent column "KF-606M" manufactured by Resonaq Co., Ltd. (formerly Showa Denko K.K.) Standard sample: Polymethyl methacrylate Solvent and mobile phase: N,N-dimethylformamide (DMF) with 10 mM lithium bromide (LiBr) added Flow rate: 0.6 mL / min Temperature: 40°C Sample solution concentration: 0.2% by mass (filtered through a filter with an opening diameter of 0.45 μm) Injection volume: 100 μL Detector: RI
[0072] [Content (Z) of Hydrophobic Monomer Units in Vinylamide-Based Copolymers] The content (Z) (mol %) of hydrophobic monomer units in vinylamide-based copolymers was determined by the following method. 1H-NMR was measured, and the integral values of the peaks derived from specific protons representing various monomer units were obtained. The integral value was then divided by the number of protons of the protons to calculate the molar amounts of various monomer units contained in the vinylamide copolymer. Thereafter, the molar amount of the hydrophobic monomer units was calculated when the molar amount of all monomer units was taken as 100%, and this value was used as the content (Z) of the hydrophobic monomer units in the vinylamide copolymer. As an example, a method for calculating the content (Z) of the hydrophobic monomer units in a vinylamide copolymer in which the vinylamide monomer units are VP, the hydrophilic monomer units are VP, and the hydrophobic monomer units are EHA will be described below. First, for a vinylamide copolymer in which the vinylamide monomer units are VP, the hydrophilic monomer units are VP, and the hydrophobic monomer units are EHA, 1 H-NMR measurement was carried out. In the following calculations, * The integral value of the peak derived from the proton of each monomer unit, denoted by H, is used. 2 CH (COOCH 2 CH (CH 2 C * H 3 ) C 3 H 6 C * H 3 The integral value (0.9 ppm) of the peak derived from the Y-VP monomer unit was determined by the proton (—CH 2 CH(-NC * H 2 CH 2 CH 2 The integrated value (3.2 ppm) of the peak derived from CO-)-) was defined as X, and the content (Z) (mol %) of the hydrophobic monomer unit in the vinylamide copolymer was calculated by the following formula: (Z) (mol %) = (Y / 6) / ((X / 2) + (Y / 6)) × 100
[0073] [Molar mass MA of polymer block (A), molar mass MB of polymer block (B), and molar mass M] The molar mass M of a vinylamide copolymer is expressed as the sum of the molar mass MA of polymer block (A) and the molar mass MB of polymer block (B). The molar mass MA of polymer block (A) and the molar mass MB of polymer block (B) were determined as follows. A vinylamide monomer was polymerized, and appropriate sampling was performed. The molar mass determined from the results of GPC measurement of the polymer block (A1) obtained up to the time of adding the hydrophobic monomer was defined as the molar mass MA1 of polymer block (A1). Furthermore, after adding the hydrophobic monomer, the molar mass determined from the results of GPC measurement of the polymer block (B) obtained by copolymerizing the hydrophobic monomer in the presence of a vinylamide monomer or a hydrophilic monomer was defined as the molar mass MB of polymer block (B). Furthermore, the molar amount MA2 of polymer block (A2) was determined from the results of GPC measurement of polymer block (A2) obtained by polymerizing vinylamide monomers in a state in which the hydrophobic monomer was consumed before the vinylamide monomer or hydrophilic monomer, and the molar ratio of the hydrophobic monomer to the vinylamide monomer or hydrophilic monomer in the reaction solution was 0.00001 or less. Here, the molar amount MA of polymer block (A) refers to the sum of the molar amount MA1 of polymer block (A1) and the molar amount MA2 of polymer block (A2). In this case, the boundary between polymer block (B) and polymer block (A2) was determined as follows. Sampling was carried out appropriately during polymerization, and the molar amount of the polymer and the hydrophobic monomer content at each sampling point were determined by GPC and 1 The point at which the molar ratio of the hydrophobic monomer to the vinylamide monomer or hydrophilic monomer in the reaction solution reaches 0.00001 was measured by H-NMR, and the value of the reactivity ratio (r VP = 0.004, r EHA= 0.53). In this case, the content of the hydrophobic monomer contained in the polymer block (A2) formed at a molar ratio of 0.00001 or less was less than 0.1 mol%. The molar masses MA and MB of the sampled polymer were determined by dividing the number average molecular weight Mn of the polymer obtained by GPC by the molecular weight of the vinylamide monomer or the hydrophilic monomer and the hydrophobic monomer (e.g., VP: 111, EHA: 184). When polymer block (A) was obtained at the beginning of polymerization, the molar mass MA of polymer block (A) was determined by measuring a polymer sampled immediately before adding the hydrophobic monomer. When polymer block (A) was obtained after polymer block (B) was obtained, the molar mass MA of polymer block (A) was determined from the difference in molar mass between the polymer sampled at the block boundary and the vinylamide copolymer after polymerization termination.
[0074] [Content (W) of Hydrophilic Monomer Unit in Polymer Block (B)] The content (W) (mol %) of the hydrophilic monomer unit in the polymer block (B) was calculated as follows: (W) (mol %)=100−((MA+MB) / MB×Z).
[0075] [Preparation of vinylamide copolymer-coated film] A vinylamide copolymer-coated film was prepared as follows. 20 parts by mass of the vinylamide copolymer was dissolved in 80 parts by mass of IPA to obtain a 20% by mass IPA coating solution of the vinylamide copolymer. The coating solution was applied to a PET film using an applicator, dried at room temperature for 24 hours, and then vacuum-dried for 24 hours to obtain a coated film with an average thickness of 50 μm.
[0076] [Evaluation of Elution Resistance of Vinylamide Copolymer] The evaluation of the elution resistance of the vinylamide copolymer was carried out as follows. A vinylamide copolymer-coated film was immersed in room temperature water (25°C) for 1 hour, and then the film was removed and vacuum dried at 40°C for 24 hours. The elution rate (mass%) of the vinylamide copolymer was calculated using the following formula, where C (g) is the mass of the coated film before immersion, D (g) is the mass of the PET film in the coated film, and E is the mass of the dried coated film after immersion. Elution rate (mass%) = (C (g) - E (g)) / (C (g) - D (g)) x 100 Using the elution rate (mass%), the elution resistance of the vinylamide copolymer was evaluated according to the following evaluation criteria. [Evaluation Criteria] A: 65% by mass or less B: More than 65% by mass and less than 90% by mass C: 90 to 100% by mass A rating of A indicates that the vinylamide copolymer has excellent elution resistance. Furthermore, even in the case of evaluation B, it can be said that the elution resistance of the vinylamide copolymer is somewhat excellent. On the other hand, in the case of evaluation C, it cannot be said that the elution resistance of the vinylamide copolymer is excellent.
[0077] [Evaluation of Adhesion Resistance (Hydrophilicity) of Vinylamide Copolymer Polymers] The adhesion resistance of a polymer is based on the fact that the surface of a medical device is covered with water molecules, making it difficult for the surface to bond with polymers such as proteins. Therefore, vinylamide copolymers are required to have water-compatible properties, i.e., hydrophilicity. The adhesion resistance (hydrophilicity) of vinylamide copolymer polymers was evaluated using the water contact angle (°) measured by the following method. A vinylamide copolymer-coated film was immersed in room temperature water (25°C) and removed after 1 hour. Water droplets adhering to the film surface were wiped off with filter paper, and the water contact angle (°) was measured under the following conditions. <Conditions> Contact angle measurement device: Fully automatic contact angle meter (DM700, manufactured by Kyowa Interface Science Co., Ltd.) Measurement temperature: Room temperature (25°C) Drop amount: 2 μL Measurement time: 60 seconds after droplet landing The adhesion resistance (hydrophilicity) of the vinylamide copolymer was evaluated using the water contact angle (°) according to the following evaluation criteria. [Evaluation Criteria] A: 0 to 89° B: Over 89° In the case of evaluation A, it can be said that the adhesion resistance (hydrophilicity) of the vinylamide copolymer is excellent. On the other hand, in the case of evaluation B, it can not be said that the adhesion resistance (hydrophilicity) of the vinylamide copolymer is excellent.
[0078] Example 1 To a reactor equipped with a stirrer, a reflux condenser, and a radical generator addition port, 100.00 parts by mass of VP, 0.15 parts by mass of MC, and 135.00 parts by mass of DMC were added, and then nitrogen was introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the reactor internal temperature reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn(A1) of the polymer at a conversion rate of 10% by mass was 10,100. Immediately thereafter, polymerization was carried out while feeding 32.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and the sampled polymer was subjected to GPC measurement and 1H-NMR measurement was performed, and the feeding was completed when the total conversion rate of VP and EHA reached 63% by mass. Thereafter, when the total conversion rate of VP and EHA reached 65% by mass, it was confirmed that EHA was completely consumed. 1 The conversion was confirmed by H-NMR. The number-average molecular weight Mn(B) at this time was 88,100. When the total conversion rate of VP and EHA reached 80% by mass, 1.6 parts by mass of DPEt was added as a polymerization inhibitor. The number-average molecular weight Mn(A2) at this time was 19,500. A vinylamide copolymer was obtained by reprecipitation of the polymerization solution with water. Details are shown in Table 1. A medical coating agent containing a vinylamide copolymer was obtained by dissolving 20.00 parts by mass of the obtained vinylamide copolymer in 80.00 parts by mass of IPA. The coating solution was applied to a PET film using an applicator, dried at room temperature for 24 hours, and then vacuum-dried for 24 hours to obtain a coated film with an average coating thickness of 50 μm. The elution resistance of the coated film and the adhesion resistance (hydrophilicity) of the polymer were evaluated, and the results are shown in Table 1.
[0079] [Example 2] 100.00 parts by mass of VP, 0.13 parts by mass of CA, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an inlet for adding a radical generator. Nitrogen was then introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and the reactor was heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn(A1) of the polymer at a conversion rate of 20% by mass was 21,000. Immediately thereafter, polymerization was carried out while feeding 22.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and the sampled polymer was subjected to GPC measurement and 1 H-NMR measurement was performed, and the feeding was completed when the total conversion rate of VP and EHA reached 58% by mass. Thereafter, when the total conversion rate of VP and EHA reached 60% by mass, it was confirmed that EHA was completely consumed. 1The polymerization was confirmed by H-NMR. The number average molecular weight Mn(B) at this time was 62,100. When the total conversion of VP and EHA reached 80% by mass, 1.60 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn(A2) at this time was 24,900. The polymerization solution was reprecipitated in water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0080] Example 3: 100.00 parts by mass of VP, 0.13 parts by mass of BZA, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an inlet for adding a radical generator. Nitrogen was then introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and the reactor was heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn(A1) of the polymer at a conversion rate of 30% by mass was 32,200. Immediately thereafter, polymerization was carried out while feeding 10.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and the sampled polymer was subjected to GPC measurement and 1 H-NMR measurement was performed, and the feeding was completed when the total conversion rate of VP and EHA reached 48% by mass. Thereafter, when the total conversion rate of VP and EHA reached 50% by mass, it was confirmed that EHA was completely consumed. 1 The polymerization was confirmed by H-NMR. The number average molecular weight Mn(B) at this time was 29,200. When the total conversion of VP and EHA reached 80% by mass, 1.60 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn(A2) at this time was 34,800. The polymerization solution was reprecipitated in water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0081] [Example 4] 100.00 parts by mass of VP, 0.13 parts by mass of CA, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an inlet for adding a radical generator, and then nitrogen was introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel and dissolved, and then nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn (A) of the polymer at a conversion rate of 25% by mass was 27,500. Immediately thereafter, polymerization was carried out while feeding 12.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and GPC measurement of the sampled polymer and 1 H-NMR measurement was performed, and when the total conversion of VP and EHA reached 80% by mass, 1.10 parts by mass of MEHQ was added as a polymerization inhibitor. The number average molecular weight Mn(B) at this time was 71,900. The polymerization solution was reprecipitated in water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0082] [Example 5] Into a reactor equipped with a stirrer, a reflux condenser, and an inlet for adding a radical generator, 100.00 parts by mass of VP and Co(acac) 2 After adding 0.23 parts by mass of and 135.00 parts by mass of DMC, nitrogen was introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel and dissolved, and then nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the reactor internal temperature reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solid content concentration. The number average molecular weight Mn (A) of the polymer at a conversion rate of 50% by mass was 53,000. Immediately after that, polymerization was carried out while feeding 41.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solid content concentration, and GPC measurement and 1H-NMR measurement was performed, and when the total conversion of VP and EHA reached 80% by mass, 1.60 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn(B) at this time was 72,600. The polymerization solution was reprecipitated with water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0083] [Example 6] 100.00 parts by mass of VP, 0.15 parts by mass of MC, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an addition port for a radical generator. Nitrogen was then introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the reactor internal temperature reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn (A) of the polymer at a conversion rate of 25% by mass was 26,500. Immediately thereafter, polymerization was carried out while feeding 33.00 parts by mass of OAAm over time. The progress of polymerization was confirmed from the solids concentration, and GPC measurement of the sampled polymer and 1 H-NMR measurement was performed, and when the total conversion of VP and OAAm reached 80% by mass, 1.60 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn(B) at this time was 92,800. The polymerization solution was reprecipitated with water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0084] [Example 7] 100.00 parts by mass of VP, 0.15 parts by mass of MC, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an addition port for a radical generator, and then nitrogen was introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn (A) of the polymer at a conversion rate of 25% by mass was 27,000. Immediately after that, polymerization was carried out while feeding 23.00 parts by mass of BA over time. The progress of polymerization was confirmed from the solids concentration, and GPC measurement of the sampled polymer and 1 H-NMR measurement was performed, and when the total conversion of VP and BA reached 80% by mass, 1.60 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn(B) at this time was 80,700. The polymerization solution was reprecipitated with water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0085] Example 8: A reactor equipped with a stirrer, a reflux condenser, and a radical generator addition port was charged with 100.00 parts by mass of VP, 0.01 parts by mass of AcSH, 19.00 parts by mass of MeOH, and 0.03 parts by mass of AIBN. Nitrogen was then introduced into the reactor to replace the atmosphere with an inert gas, and the contents were heated and stirred until the reactor temperature reached 60°C. Polymerization was carried out while gradually feeding 0.17 parts by mass of AcSH and 1.90 parts by mass of MeOH. The progress of polymerization was confirmed from the solids concentration, and GPC measurement of sampled polymers was performed. When the VP conversion reached 50% by mass, the vessel was cooled to terminate the polymerization. The number average molecular weight Mn (A) at this time was 54,400. The polymerization solution was reprecipitated with hexane, and 450.00 parts by weight of methanol, 45.00 parts by weight of water, and 5.00 parts by weight of sodium hydroxide were added to the extracted polymer. After heating and stirring at 40 ° C, the mixture was reprecipitated with hexane to obtain a vinylamide polymer having a mercapto group at the end. 50.00 parts by weight of VP polymer having a mercapto group at the end, 200.00 parts by weight of DMC, 73.00 parts by weight of HEMA, 36.00 parts by weight of St, and 0.09 parts by weight of AIBN were added. Nitrogen was then introduced into the reactor to perform inert gas replacement, and the reactor was heated and stirred to an internal temperature of 60 ° C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. When the total conversion of HEMA and St reached 80% by weight, 0.20 parts by weight of MEHQ was added as a polymerization inhibitor. The number average molecular weight Mn (B) at this time was 102,900. The polymerization solution was reprecipitated in water to obtain a vinylamide copolymer, the details of which are shown in Table 1.
[0086] [Example 9] 100.00 parts by mass of VP, 0.15 parts by mass of MC, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an addition port for a radical generator. Nitrogen was then introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn (A) of the polymer at a conversion rate of 25% by mass was 27,300. Immediately thereafter, polymerization was carried out while feeding a mixed solution of 17.00 parts by mass of EHA and 12.00 parts by mass of MEA over time. The progress of polymerization was confirmed from the solids concentration, and GPC measurement of the sampled polymer and 1 H-NMR measurement was performed, and when the total conversion of VP, EHA, and MEA reached 80% by mass, 1.60 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn(B) at this time was 87,100. The polymerization solution was reprecipitated with water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0087] [Example 10] 100.00 parts by mass of CL, 0.12 parts by mass of MC, and 107.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an addition port for a radical generator. Nitrogen was then introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.22 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn (A) of the polymer at a conversion rate of 25% by mass was 34,500. Immediately thereafter, polymerization was carried out while feeding 26.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and GPC measurement of the sampled polymer and 1H-NMR measurement was performed, and when the total conversion of CL and EHA reached 80% by mass, 1.30 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn(B) at this time was 107,100. The polymerization solution was reprecipitated with water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0088] Example 11 Into a reactor equipped with a stirrer, a reflux condenser, and an inlet for adding a radical generator, 100.00 parts by mass of VP and Co(acac) 2 After adding 0.07 parts by mass of and 35.00 parts by mass of DMC, nitrogen was introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.08 parts by mass of V-70 were added to a preparation vessel and dissolved, and then nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the reactor internal temperature reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn (A) of the polymer at a conversion rate of 25% by mass was 96,000. Immediately after that, polymerization was carried out while feeding 26.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and GPC measurement and 1 H-NMR measurement was performed, and when the total conversion of VP and EHA reached 80% by mass, 0.50 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn(B) at this time was 309,800. The polymerization solution was reprecipitated in water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0089] [Example 12] 100.00 parts by mass of VP, 0.25 parts by mass of BM1434, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an addition port for a radical generator. Nitrogen was then introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.06 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn (A) of the polymer at a conversion rate of 10% by mass was 11,000. Immediately thereafter, polymerization was carried out while feeding 15.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and GPC measurement of the sampled polymer and 1 H-NMR measurement was performed, and when the total conversion of VP and EHA reached 40% by mass, 1.60 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn(B) at this time was 43,500. The polymerization solution was reprecipitated with water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0090] [Example 13] 100.00 parts by mass of VP, 0.13 parts by mass of CA, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an addition port for a radical generator, and then nitrogen was introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn (A) of the polymer at a conversion rate of 10% by mass was 10,900. Immediately thereafter, polymerization was carried out while feeding 41.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and GPC measurement of the sampled polymer and 1H-NMR measurement was performed, and when the total conversion of VP and EHA reached 80% by mass, 1.10 parts by mass of MEHQ was added as a polymerization inhibitor. The number average molecular weight Mn(B) at this time was 118,000. The polymerization solution was reprecipitated in water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0091] [Example 14] 100.00 parts by mass of VP, 0.13 parts by mass of CA, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an addition port for a radical generator, and then nitrogen was introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn (A) of the polymer at a conversion rate of 75% by mass was 82,500. Immediately thereafter, polymerization was carried out while feeding 10.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and GPC measurement of the sampled polymer and 1 H-NMR measurement was performed, and when the total conversion of VP and EHA reached 80% by mass, 1.10 parts by mass of MEHQ was added as a polymerization inhibitor. The number average molecular weight Mn(B) at this time was 15,000. The polymerization solution was reprecipitated in water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0092] [Example 15] 100.00 parts by mass of VP, 0.13 parts by mass of CA, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an addition port for a radical generator, and then nitrogen was introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn (A1) of the polymer at a conversion rate of 10% by mass was 10,300. Immediately thereafter, polymerization was carried out while feeding 5.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and GPC measurement of the sampled polymer and 1 H-NMR measurement was performed, and the feeding was completed when the total conversion rate of VP and EHA reached 63% by mass. Thereafter, when the total conversion rate of VP and EHA reached 65% by mass, it was confirmed that EHA was completely consumed. 1 The polymerization was confirmed by H-NMR. The number average molecular weight Mn(B) at this time was 64,900. When the total conversion of VP and EHA reached 80% by mass, 1.10 parts by mass of MEHQ was added as a polymerization inhibitor. The number average molecular weight Mn(A2) at this time was 16,800. The polymerization solution was reprecipitated with water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0093] Example 16 Into a reactor equipped with a stirrer, a reflux condenser, and an inlet for adding a radical generator, 100.00 parts by mass of VP and Co(acac) 2After adding 0.23 parts by mass of and 135.00 parts by mass of DMC, nitrogen was introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel and dissolved, and then nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the reactor internal temperature reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn(A1) of the polymer at a conversion rate of 10% by mass was 10,500. Immediately after that, polymerization was carried out while feeding 99.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and GPC measurement and 1 H-NMR measurement was performed, and the feeding was completed when the total conversion rate of VP and EHA reached 63% by mass. Thereafter, when the total conversion rate of VP and EHA reached 65% by mass, it was confirmed that EHA was completely consumed. 1 The polymerization was confirmed by H-NMR. The number average molecular weight Mn(B) at this time was 146,700. When the total conversion of VP and EHA reached 80% by mass, 1.60 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn(A2) at this time was 26,200. The polymerization solution was reprecipitated in water to obtain a vinylamide copolymer. Details are shown in Table 1.
[0094] [Comparative Example 1] 100.00 parts by mass of EHA, 0.15 parts by mass of BM1434, and 80.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an inlet for adding a radical generator, and then nitrogen was introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.03 parts by mass of V-70 were added to a preparation vessel and dissolved, and then nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. Polymer block (A) at a conversion rate of 50% by mass * Number average molecular weight Mn (A) *The viscosity was 90,900. The reactor was quickly cooled to 10°C to terminate the polymerization, and the solvent and residual monomers were removed under reduced pressure. Subsequently, 100.00 parts by mass of VP, which had been previously substituted with an inert gas, 140.00 parts by mass of DMC, and 0.03 parts by mass of V-70 were added, and immediately thereafter, polymerization was carried out while feeding 41.00 parts by mass of EHA over time. The progress of the polymerization was confirmed from the solid content concentration, and the polymer sample was subjected to GPC measurement and 1 H-NMR measurement was performed, and when the total conversion of VP and EHA reached 40% by mass, 1.60 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn(B) at this time was 73,300. A vinylamide copolymer was obtained by reprecipitation with water. Details are shown in Table 1. The polymer of Comparative Example 1 was obtained by adding a polymer block (A) composed of hydrophobic monomer units instead of a polymer block (A) containing 50 mol% or more of vinylamide monomer units. * However, in Table 1, in order to facilitate comparison with the examples, the polymer block (A) composed of hydrophobic monomer units is * The information regarding the above is given in parentheses in the "Polymer Block (A)" column.
[0095] [Comparative Example 2] 100.00 parts by mass of VP, 0.15 parts by mass of MC, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an addition port for a radical generator, and then nitrogen was introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the internal temperature of the reactor reached 45 ° C. Immediately thereafter, polymerization was carried out while feeding 66.00 parts by mass of EHA over time. The progress of polymerization was confirmed from the solids concentration, and sampled polymers were subjected to GPC measurement and 1H-NMR measurement was performed, and when the total conversion of VP and EHA reached 80% by mass, 1.60 parts by mass of DPEt was added as a polymerization inhibitor. The number-average molecular weight Mn(B) of the polymer at this time was 145,500. A vinylamide copolymer was obtained by reprecipitation of the polymerization solution with water. Details are shown in Table 1. Note that the polymer of Comparative Example 2 has a polymer block (B) with a hydrophilic monomer unit content (W) of 70 mol% and does not have a polymer block (A) containing 50 mol% or more of vinylamide monomer units. Therefore, in Table 1, information about the polymer is listed only in the "Polymer Block (B)" column.
[0096] [Comparative Example 3] 100.00 parts by mass of VP, 0.25 parts by mass of BM1434, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and an addition port for a radical generator. Nitrogen was then introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.06 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and the reactor was heated and stirred so that the internal temperature of the reactor reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. The number average molecular weight Mn (A) of the polymer at a conversion rate of 70% by mass was 77,100. The reactor was quickly cooled to 10°C to terminate the polymerization. The polymerization solution was reprecipitated with hexane under an inert atmosphere to extract a vinylamide polymer, and the hexane was removed under reduced pressure. Subsequently, 100.00 parts by mass of EHA, which had been previously purged with an inert gas, 85.00 parts by mass of DMC, and 0.01 parts by mass of V-70 were added, and the mixture was heated and stirred so that the reactor internal temperature reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solid content concentration. When the conversion rate of EHA reached 30% by mass, 1.00 parts by mass of DPEt was added as a polymerization inhibitor. Polymer block (B) at this time * Number average molecular weight Mn(B) * The molecular weight of the polymer was 54,000. The polymerization solution was reprecipitated in water to obtain a vinylamide copolymer. Details are shown in Table 1. The polymer of Comparative Example 3 was prepared by using a polymer block (B) composed of hydrophobic monomer units instead of the polymer block (B) containing 30 mol % or more of hydrophilic monomer units. *However, in Table 1, in order to facilitate comparison with the examples, the polymer block (B) composed of hydrophobic monomer units is * The information regarding the above is given in parentheses in the "Polymer Block (B)" column.
[0097] [Comparative Example 4] 100.00 parts by mass of VP, 0.15 parts by mass of MC, and 135.00 parts by mass of DMC were added to a reactor equipped with a stirrer, a reflux condenser, and a radical generator addition port. Nitrogen was then introduced into the reactor to perform inert gas replacement. 5.00 parts by mass of DMC and 0.28 parts by mass of V-70 were added to a preparation vessel, and after dissolution, nitrogen was introduced to perform inert gas replacement. The solution in the preparation vessel was added to the reactor, and then heated and stirred so that the reactor internal temperature reached 45°C. Sampling was performed as appropriate, and the progress of polymerization was confirmed from the solids concentration. When the conversion rate reached 80% by mass, 1.60 parts by mass of DPEt was added as a polymerization inhibitor. The number average molecular weight Mn (A) at this time was 98,800. A vinylamide polymer was obtained by reprecipitation with hexane. Details are shown in Table 1. The polymer of Comparative Example 4 is a polymer composed of vinylamide-based monomer units, i.e., a polymer block (A) containing 50 mol % or more of vinylamide-based monomer units, and does not include a polymer block (B) containing hydrophilic monomer units and hydrophobic monomer units. Therefore, in Table 1, information about the polymer is listed only in the "polymer block (A)" column.
[0098]
[0099] The vinylamide copolymers of Examples 1 to 12 had resistance to elution that was at least slightly excellent, and also had excellent adhesion resistance (hydrophilicity) of the polymer.
[0100] The vinylamide copolymer of Example 13 had a high ratio of MB, i.e., polymer block (B), to MA. The vinylamide copolymer of Example 13 was excellent in both elution resistance and adhesion resistance (hydrophilicity) of the polymer.
[0101] The vinylamide copolymer of Example 14 has a small ratio of MB, i.e., polymer block (B), to MA. The vinylamide copolymer of Example 14 was somewhat excellent in elution resistance and also excellent in polymer adhesion resistance (hydrophilicity).
[0102] The vinylamide copolymer of Example 15 has a large content (W) of hydrophilic monomer units in the polymer block (B). The vinylamide copolymer of Example 15 was somewhat excellent in elution resistance and also excellent in polymer adhesion resistance (hydrophilicity).
[0103] The vinylamide copolymer of Example 16 had a low content (W) of hydrophilic monomer units in the polymer block (B). The vinylamide copolymer of Example 16 had excellent resistance to elution and excellent adhesion resistance (hydrophilicity) of polymers.
[0104] The polymer of Comparative Example 1 has a polymer block (A) composed of hydrophobic monomer units instead of the polymer block (A) containing 50 mol % or more of vinylamide-based monomer units. * The copolymer of Comparative Example 1 was excellent in resistance to elution, but was poor in adhesion resistance (hydrophilicity) of the polymer.
[0105] The polymer of Comparative Example 2 was a polymer having a polymer block (B) with a hydrophilic monomer unit content (W) of 70 mol % and no polymer block (A) containing 50 mol % or more of vinylamide monomer units. The vinylamide copolymer of Comparative Example 2 was excellent in elution resistance but poor in polymer adhesion resistance (hydrophilicity).
[0106] The polymer of Comparative Example 3 is a polymer block (B) composed of hydrophobic monomer units instead of the polymer block (B) containing 30 mol % or more of hydrophilic monomer units. * The vinylamide copolymer of Comparative Example 3 was excellent in resistance to elution, but was poor in adhesion resistance (hydrophilicity) of the polymer.
[0107] The polymer of Comparative Example 4 is a polymer composed of vinylamide-based monomer units, i.e., a polymer block (A) containing 50 mol % or more vinylamide-based monomer units, and is a polymer that does not include a polymer block (B) containing hydrophilic monomer units and hydrophobic monomer units. The vinylamide-based copolymer of Comparative Example 4 was excellent in adhesion resistance (hydrophilicity) of the polymer, but was poor in elution resistance.
Claims
1. A vinylamide copolymer comprising at least one polymer block (A) containing 50 mol % or more of vinylamide monomer units, and at least one polymer block (B) containing hydrophilic monomer units and hydrophobic monomer units.
2. The vinylamide copolymer according to claim 1, wherein the vinylamide monomer constituting the vinylamide monomer unit includes at least one member selected from the group consisting of vinylacetamide, vinylpyrrolidone, vinylcaprolactam, vinylmethylacetamide, vinylformamide, vinylcarbazole, vinylimidazole, vinylphthalimide, vinylnaphthalimide, and vinylindole.
3. The vinylamide copolymer according to claim 1 or 2, wherein the hydrophilic monomer constituting the hydrophilic monomer unit includes at least one member selected from the group consisting of vinylacetamide, vinylpyrrolidone, and vinylcaprolactam.
4. The vinylamide copolymer according to claim 1 or 2, wherein the hydrophobic monomer constituting the hydrophobic monomer unit includes at least one selected from the group consisting of acrylate monomers, acrylamide monomers, and styrene monomers.
5. The vinylamide copolymer according to claim 1 or 2, wherein the content of the hydrophobic monomer constituting the hydrophobic monomer unit is 2 to 60 mol % based on 100 mol % of all monomers constituting the vinylamide copolymer.
6. A vinylamide copolymer according to claim 1 or 2, wherein the ratio MA / MB of the molar amount MA of the polymer block (A) to the molar amount MB of the polymer block (B) is 5 / 95 to 95 / 5.
7. The vinylamide copolymer according to claim 1 or 2, wherein the content of the hydrophilic monomer constituting the hydrophilic monomer unit is 30 to 97 mol % in 100 mol % of all monomers constituting the polymer block (B).
8. The vinylamide copolymer according to claim 1 or 2, wherein the molar weight M of the vinylamide copolymer is 300 to 5,000.
9. The vinylamide copolymer according to claim 1 or 2, wherein the content of the vinylamide monomer constituting the vinylamide monomer unit is 96 mol % or more in 100 mol % of all monomers constituting the polymer block (A).
10. A method for producing a vinylamide copolymer, comprising at least one step each of: step (A) of polymerizing a vinylamide monomer to produce a polymer block (A) containing a vinylamide monomer unit; and step (B) of polymerizing a hydrophilic monomer and a hydrophobic monomer to produce a polymer block (B) containing a hydrophilic monomer unit and a hydrophobic monomer unit.
11. The method for producing a vinylamide copolymer according to claim 10, wherein the polymerization is carried out in the presence of a polymerization inhibitor in at least one step selected from the group consisting of steps (A) and (B).
12. A vinylamide copolymer composition comprising the vinylamide copolymer according to claim 1 or 2 and one or more ingredients selected from the group consisting of cinnamic acids, organic cobalt complexes and thiocarbonyl compounds.
13. A medical coating agent comprising the vinylamide copolymer according to claim 1 or 2.
14. A medical coating agent comprising the vinylamide copolymer composition according to claim 12.
15. A medical covering material comprising a coating film of the medical coating agent according to claim 13.
16. A medical device comprising the medical covering material according to claim 15.
Citation Information
Patent Citations
Block ethylene copolymer containing vinyl lactam block, cosmetics or drug composition containing the copolymer, and cosmetic use of the copolymer
JP2005089754A
Block ethylenic copolymer containing vinyl lactam block, cosmetic or pharmaceutical composition containing the same, and use of the polymer for cosmetic
JP2005097611A
Anb block copolymers containing poly(vinylpyrrolidone) units, medical devices, and methods
JP2005518841A
Medical device with wet hydrophilic coating
JP2008515495A
Polymers for creating blood-compatible surfaces
JP2012519540A
